• In May 2026, FactSet Research Systems Inc. announced a partnership with Valutico to create an integrated, end-to-end valuation workflow for private capital markets, linking its Cobalt portfolio monitoring platform directly to Valutico’s valuation tools and FactSet’s market data.
• This collaboration aims to replace fragmented, spreadsheet-heavy processes with a single connected system, giving private-market investors more frequent, consistent and institutionally robust portfolio valuations.
• We’ll now explore how this enhanced private-markets valuation workflow could influence FactSet’s broader investment narrative and long-term competitive positioning.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

FactSet Research Systems Investment Narrative Recap

To own FactSet, you need to believe it can convert its data, software and AI investments into steady, subscription driven growth despite mixed capital markets conditions and higher tech spending. The Valutico partnership strengthens its private markets offering, but it does not materially change the near term picture, where softer pricing tailwinds and pressure on asset manager and bank budgets remain the key catalyst and risk to watch.

The most relevant recent announcement alongside the Valutico news is FactSet’s dividend increase to US$1.1600 per share, payable in June 2026. For many shareholders, this reinforces the company’s focus on consistent cash returns at a time when the share price has fallen sharply and earnings growth has slowed, which may influence how you weigh the short term risks against the longer term product investments now rolling into client workflows.

Yet behind these product wins, investors should be aware that rising technology and cloud costs could still...

FactSet Research Systems' narrative projects $2.8 billion revenue and $712.8 million earnings by 2029. This requires 5.5% yearly revenue growth and about a $125 million earnings increase from $587.8 million today.

Uncover how FactSet Research Systems' forecasts yield a $252.44 fair value, a 19% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming revenue of about US$2.8 billion and earnings near US$726 million by 2028, which is far more upbeat than consensus and leans heavily on faster AI enabled adoption across workflows like the new Valutico integration, while others are more cautious about whether these high expectations and the selected risk of rising structural tech costs will hold up as new information emerges.

Explore 6 other fair value estimates on FactSet Research Systems - why the stock might be worth just $252.44!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your FactSet Research Systems research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.
• Our free FactSet Research Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FactSet Research Systems' overall financial health at a glance.

Curious About Other Options?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 42 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.